mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |